Results Disclaimer: Individual results vary and are not guaranteed
It is often described as a triple agonist, which means it is designed to stimulate three receptor systems
GLP-1 drugs, which include medications used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have greatly increased in popularity in recent years due to their demonstrated effectiveness
They have a low risk of causing hypoglycemia, and they also promote satiety by central nervous effects and by slowing gastric emptying
Schedule an appointment today with the neurology experts at the Center for Neurology and Spine in Phoenix, Arizona , and discover how were combining innovation, compassion, and evidence-based care to help our patients live better, longer lives.